These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
186 related items for PubMed ID: 19653472
21. Vascular endothelial growth factor in patients with exudative age-related macular degeneration treated with ranibizumab. Muether PS, Hermann MM, Viebahn U, Kirchhof B, Fauser S. Ophthalmology; 2012 Oct; 119(10):2082-6. PubMed ID: 22920670 [Abstract] [Full Text] [Related]
22. Comparison of two intravitreal ranibizumab treatment schedules for neovascular age-related macular degeneration. Gupta B, Adewoyin T, Patel SK, Sivaprasad S. Br J Ophthalmol; 2011 Mar; 95(3):386-90. PubMed ID: 20693484 [Abstract] [Full Text] [Related]
24. Age-related macular degeneration, anti-vascular endothelial growth factor agents, and short-term mortality: a postmarketing medication safety and surveillance study. French DD, Margo CE. Retina; 2011 Jun; 31(6):1036-42. PubMed ID: 21836410 [Abstract] [Full Text] [Related]
25. Intravitreal bevacizumab in vascular pigment epithelium detachment as a result of subfoveal occult choroidal neovascularization in age-related macular degeneration. Ach T, Hoeh AE, Ruppenstein M, Kretz FT, Dithmar S. Retina; 2010 Oct; 30(9):1420-5. PubMed ID: 20543764 [Abstract] [Full Text] [Related]
28. Emerging therapies for neovascular age-related macular degeneration: state of the art. Donati G. Ophthalmologica; 2007 Mar; 221(6):366-77. PubMed ID: 17947822 [Abstract] [Full Text] [Related]